Research Topics
| Yoo Jin KimSummaryAffiliation: Saarland University Country: Germany Publications
| Collaborators
|
Detail Information
Publications
Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomasY J Kim
Institute of Neuropathology, University of the Saarland, School of Medicine, Homburg Saar, Germany
Clin Neuropathol 25:67-73. 2006..Therefore, an automated computer-based method was developed, which is able to identify and analyze immunolabeled and hematoxylin-stained nuclei in digital images of routine immunohistochemical slides...
Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parametersYoo Jin Kim
School of Medicine, Institute of Neuropathology, Saarland University, Bldg 90 3, 66421 Homburg Saar, Germany
Virchows Arch 449:529-38. 2006..In particular, biologically aggressive meningiomas of histologically benign or "borderline" phenotype could be therefore identified by ALPL detection followed by 1p in situ hybridization...
Hyperdiploidy defines a distinct cytogenetic entity of meningiomasRalf Ketter
Neurosurgical Clinic, Saarland University, Homburg Saar, Germany
J Neurooncol 83:213-21. 2007....
Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomasRalf Ketter
Department of Neurosurgery, Saarland University, Homburg Saar, Germany
Neurosurgery 62:61-9; discussion 69-70. 2008..Progression of meningiomas is associated with a non-random pattern of secondary losses of other autosomes. Deletion of the short arm of one chromosome 1 is a decisive step to anaplastic growth in meningiomas...
Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomasYoo Jin Kim
Institute of Neuropathology, Saarland University, School of Medicine, Homburg Saar, Germany
Am J Clin Pathol 128:118-25. 2007..In contrast with the Ki-67 LI, H&E MI and PHH3 MI also remained as independent predictors in the multivariate Cox hazards modeling (P = .0007 and P = .0004, respectively)...
Diffuse high-grade gliomas as second malignant neoplasms after radio-chemotherapy for pediatric malignanciesBernd F M Romeike
Institut für Neuropathologie, Universitatsklinikum des Saarlandes, 66421, Homburg Saar, Germany
Childs Nerv Syst 23:185-93. 2007..Diffuse high-grade gliomas are known to develop in children after cranial irradiation for other malignancies. Here, clinicopathological characteristics are outlined...
Fully automated segmentation and morphometrical analysis of muscle fiber imagesYoo Jin Kim
Institute of Neuropathology, Saarland University, School of Medicine, Homburg Saar, Germany
Cytometry A 71:8-15. 2007..We therefore propose an automated image analysis method for objective, reproducible, and time-saving measurement of muscle fibers in routinely hematoxylin-eosin stained cryostat sections...
A 76-year-old woman with a history of bladder cancer and new brain lesionYoo-Jin Kim
Institute of Neuropathology, University of the Saarland, School of Medicine, Homburg/Saar, Germany
Brain Pathol 17:329-30. 2007
Efficacy of up-front treatment with a double stem cell transplantation in multiple myelomaKi-Seong Eom
Catholic Hematopoietic Stem Cell Transplantation Center, St Mary's Hospital, Catholic University of Korea, Youngdungpo-gu, Seoul 150-713, South Korea
Jpn J Clin Oncol 36:432-8. 2006..CONCLUSIONS: A second SCT is the most significant factor for an improved PFS and OS after the first ASCT (P < 0.001, respectively). Up-front double SCT is needed to improve the OS and PFS in patients with MM...
The significance of minimal residual disease kinetics in adults with newly diagnosed PML-RARalpha-positive acute promyelocytic leukemia: results of a prospective trialSeok Lee
Catholic Hematopoietic Stem Cell Transplantation Center, College of Medicine, The Catholic University of Korea, Seoul, Korea
Haematologica 91:671-4. 2006..7+/-13.2% versus 7.3+/-4.1%, p<0.001) and disease-free survival (14.3+/-13.2% versus 91.2%+/-4.3%, p<0.001). Prospective MRD monitoring may allow us to identify subgroups of patients at high risk of relapse earlier during treatment...
Gemtuzumab ozogamicin in combination with attenuated doses of standard induction chemotherapy can successfully induce complete remission without increasing toxicity in patients with acute myeloid leukemia aged 55 or olderKi Seong Eom
Catholic Hematopoietic Stem Cell Transplantation Center, St Mary s Hospital, The Catholic University of Korea, Seoul, Korea
Eur J Haematol 79:398-404. 2007....
